Key role of patients in clinical trials

R. Mccrory (Co Down, Ireland)

Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Number: 17



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Mccrory (Co Down, Ireland). Key role of patients in clinical trials. Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How to accelerate bringing new drugs to patients: role of clinical trials networks
Source: International Congress 2019 – Rare lung diseases
Year: 2019


The role of phonophoresis in patients with COPD: a randomized clinical trial
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Patient perspective of participation in COVID-19 clinical trials
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021


Current clinical trials
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017


Emerging concepts in outcome assessment for COPD clinical trials
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007

Establishing new treatments: the role of RCTs
Source: Virtual Congress 2020 – Tuberculosis: learning from the WHO global health emergencies
Year: 2020


Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017


Patients’ experience with and knowledge on clinical trials.
Source: Virtual Congress 2020 – Evaluation of knowledge transfer into clinical practice
Year: 2020


COPD treatment from pathophysiology to clinical trials
Source: ERS Live 2007
Year: 2007

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
Source: Eur Respir J, 56 (3) 2002114; 10.1183/13993003.02114-2020
Year: 2020



Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response ? A meta-analysis.
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD
Source: International Congress 2017 – Management of COPD
Year: 2017


Selecting patients in clinical practice
Source: School Course 2012 - Practical Issues in Pulmonary Rehabilitation
Year: 2012



Negative clinical trials in sarcoidosis: failed therapies or flawed study design?
Source: Eur Respir J 2014; 44: 1123-1126
Year: 2014


The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020
Year: 2020